Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01202136 · ClinicalTrials.gov registry record
The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 477
- Enrollment target
NCT01202136: Completed study, sponsored by Johns Hopkins University.
NCT01202136 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 477 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01202136 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 477 participants
- Enrollment target
Study Summary
The aim is to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.
Primary Outcome
1)to determine the prevalence and incidence of malignancy in pancreatic cysts according to cyst size and concerning features
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2012-10 |
| Est. Completion | 2019-09 |
What the finished NCT01202136 record still lists
NCT01202136 is an observational study that tracks outcomes without assigning an intervention. The registered 477 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01202136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01202136 about?
NCT01202136 is a clinical study titled "The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study". The aim is to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.
What is the current status of trial NCT01202136?
This trial is currently completed. The enrollment target is 477 participants. The study started on 2012-10. Estimated completion is 2019-09.
Who is sponsoring clinical trial NCT01202136?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03911700 · 477 participants · NA
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
- NCT06997497 · 477 participants · Phase 3
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- NCT05446272 · 478 participants · NA
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
- NCT06172296 · 478 participants · Phase 3
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia